Genetic surveillance of Plasmodium falciparum (Pf) can track antimalarial-resistant strains, to inform decision-making by National Malaria Control Programmes (NMCPs). The GenRe-Mekong project prospectively collected 5982 samples in the Greater Mekong Subregion (GMS) between 2017 and 2022, genotyping drug resistance markers, and barcodes that recapitulate genetic variation. Genotypes were analyzed with the grcMalaria R package, first described in this paper, to translate genetic epidemiology data into actionable visual information. Since 2020, Pf incidences decreased rapidly, accompanied by a decline of dihydroartemisinin-piperaquine (DHA-PPQ) resistant lineages, previously dominant in the eastern GMS. The frequency of plasmepsin2/3 amplifications, conferring piperaquine resistance, dropped from 62% in 2017-2019 to 2% in 2022, coinciding with a switch in frontline therapy in Cambodia, Thailand, and Vietnam. While regional artemisinin resistance levels remained high, no evidence of emerging mefloquine resistance was found. Routine genetic surveillance proved valuable in monitoring rapid parasite population changes in response to public health interventions, providing actionable information for NMCPs.
Affinity‐based electrochemical biosensors hold promise for detecting pathogenic bacteria in environmental applications. This study focuses on detecting gram‐positive bacteria, which can cause fatal infections and are a major global mortality factor. An electrochemical biosensor platform using high‐throughput 16‐channel gold disk electrodes (16‐GDEs) inspired by bio‐microelectromechanical systems (BioMEMS) is developed, it incorporates a nanocomposite (AuNPs@Ti3C2Tz) with sandwich peptide structures to enhance electroconductivity and biological antifouling. Using AuNPs@Ti3C2Tz‐coated 16‐GDEs, sensitive biosensors for gram‐positive bacteria (Staphylococcus aureus, Bacillus cereus, or Micrococcus luteus) are constructed and validated in fresh‐water samples by spiking with bacteria, which showed linear correlations between normalized peak current and logarithmic concentrations of the target bacteria (adjusted R‐square ≥ 0.93). A single high‐throughput platform containing biosensors for S. aureus, M. luteus, or B. cereus is also developed, exhibiting specific responses without any cross‐reactivity in real samples. This platform enabled sensitive simultaneous detection of multiple analytes in environmental samples (500 CFU mL⁻¹) and can be applied to detect any target analyte with a suitable peptide pair. The strategy is to implement a quantitative real‐time polymerase chain reaction (RT‐qPCR) adaptive sensing device to successfully detect gram‐positive bacteria. The nanocomposite‐enabled electrochemical biosensor platform on 16‐GDEs offers a valuable tool for environmental and clinical diagnostics.